European Drug Regulator Slaps Safety Warning On J&J Jab Due To Blood-Clot Links

While Europe grapples with its own vaccine safety scandal, the EMA, the same EU pharma regulator that has insisted that the AstraZeneca-Oxford jab’s benefits far outweigh its risk, has just poured cold water on J&J’s vaccine.

Although the EMA said the reported combination of blood clots and low blood platelets is very rare, and the overall benefits of J&J’s COVID-19 Vaccine Janssen in preventing COVID-19 outweighs the risks of side effects, the EMA has decided to affix a safety warning to the J&J jab – a warning that EMA neglected to impose on the AstraZeneca jab that is so critical to the Continent’s vaccination program.

Continue reading the original article here. Archived here.